| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abuse of psychotropic drugs and help seeking behaviour
|
Ladewig, D
|
|
1991
|
1 |
3 |
p. 258-259
2 p.
|
artikel
|
| 2 |
A clinical trial of clopixol — implications for antipsychotic drug treatment and research
|
Ivanov, B
|
|
1991
|
1 |
3 |
p. 429-
1 p.
|
artikel
|
| 3 |
A comparison of the psychopharmacological profile of centbutindole, haloperidol, chlorpromazine and pimozide
|
Palit, G
|
|
1991
|
1 |
3 |
p. 410-411
2 p.
|
artikel
|
| 4 |
A double-blind comparative study of sulpiride and chlorpromazine in patients with acute schizophrenia
|
Toone, B.K
|
|
1991
|
1 |
3 |
p. 428-
1 p.
|
artikel
|
| 5 |
A double-blind comparison of high-dose nefazodone, low-dose nefazodone, and placebo in the treatment of depressed outpatients
|
Mendels, J
|
|
1991
|
1 |
3 |
p. 451-452
2 p.
|
artikel
|
| 6 |
A double-blind, multicentre, placebo-controlled study of sertraline in obsessive-compulsive disorder
|
Chouinard, G
|
|
1991
|
1 |
3 |
p. 363-364
2 p.
|
artikel
|
| 7 |
Adverse drug reaction in long term antidepressant treatment
|
Rouillon, F
|
|
1991
|
1 |
3 |
p. 216-218
3 p.
|
artikel
|
| 8 |
Alcohol craving treated with fluvoxamin
|
Bille, A
|
|
1991
|
1 |
3 |
p. 450-
1 p.
|
artikel
|
| 9 |
Aliphatic and aromatic amino acetamides: novel substrates and specific reversible inhibitors of monoamine oxidase B
|
Youdim, M.B.H
|
|
1991
|
1 |
3 |
p. 313-315
3 p.
|
artikel
|
| 10 |
Alpidem, an omega-1 receptor-selective partial agonist: a new approach to anxiety treatment
|
Zivkovic, B
|
|
1991
|
1 |
3 |
p. 202-205
4 p.
|
artikel
|
| 11 |
Alterations of nonspecific immunity of rats selected for extreme values of platelet serotonin levels
|
Cicin-Sain, L
|
|
1991
|
1 |
3 |
p. 416-417
2 p.
|
artikel
|
| 12 |
Amineptine versus fluoxetine in the treatment of outpatients with major depressive disorders
|
Dalery, J
|
|
1991
|
1 |
3 |
p. 449-450
2 p.
|
artikel
|
| 13 |
A multicenter double-blind comparative trial of raclopride versus haloperidol in schizophrenia
|
Casey, D.E
|
|
1991
|
1 |
3 |
p. 428-429
2 p.
|
artikel
|
| 14 |
A multicenter double blind randomized dose titration study comparing paroxetine and amitriptyline in major depression
|
Geretsegger, C
|
|
1991
|
1 |
3 |
p. 438-
1 p.
|
artikel
|
| 15 |
A multicentre double blind comparative study between paroxetine and maprotiline in major depression
|
Laruelle, M
|
|
1991
|
1 |
3 |
p. 439-
1 p.
|
artikel
|
| 16 |
A multicentre, double blind pharmacokinetic study of paroxetine and amitriptyline in elderly depressed patients
|
Hebenstreit, G.F
|
|
1991
|
1 |
3 |
p. 440-441
2 p.
|
artikel
|
| 17 |
A multicentre, double-blind, randomized, prospective study comparing efficacy and safety of moclobemide and dothiepin in major depression in a general practice setting
|
Hill, S.A
|
|
1991
|
1 |
3 |
p. 456-
1 p.
|
artikel
|
| 18 |
An animal model of affect: biology, pharmacology and genetics
|
Henn, F.A
|
|
1991
|
1 |
3 |
p. 300-302
3 p.
|
artikel
|
| 19 |
An animal model of panic disorder?
|
Martin, P
|
|
1991
|
1 |
3 |
p. 400-
1 p.
|
artikel
|
| 20 |
A new tool for pharmaco-EEG and EPs mapping kinetics: the dynamic statistical decision tree (DSDT)
|
Dago, K.T
|
|
1991
|
1 |
3 |
p. 477-478
2 p.
|
artikel
|
| 21 |
An improved method for measuring drug effects on the Critical Fusion Frequency (CFF)
|
Vuurman, E
|
|
1991
|
1 |
3 |
p. 467-
1 p.
|
artikel
|
| 22 |
An investigation to determine the relationship between plasma levels of the 5-HT reuptake inhibitor sertraline and efficacy/side effects in outpatients with major depression
|
Brown, W
|
|
1991
|
1 |
3 |
p. 446-
1 p.
|
artikel
|
| 23 |
Antidepressant action of lithium gluconate alone and in co-administration with tricyclics in the learned helplessness paradigm in rats
|
Martin, P
|
|
1991
|
1 |
3 |
p. 404-405
2 p.
|
artikel
|
| 24 |
Antidepressant effect of carbamazepine — the role of dopaminergic and noradrenergic agents
|
Sluzewska, A
|
|
1991
|
1 |
3 |
p. 404-
1 p.
|
artikel
|
| 25 |
Antipsychotic drugs acting via unusual mechanisms: clinical and therapeutic approach
|
Lecrubier, Y
|
|
1991
|
1 |
3 |
p. 255-
1 p.
|
artikel
|
| 26 |
A possible role of dopamine in some forms of obsessive compulsive disorder
|
Goodman, W.K
|
|
1991
|
1 |
3 |
p. 279-
1 p.
|
artikel
|
| 27 |
Application of cloned genes for γ-aminobutyric acid receptors in the human brain: potential relationship to some inherited brain disorders
|
Barnard, E.A
|
|
1991
|
1 |
3 |
p. 344-345
2 p.
|
artikel
|
| 28 |
A review of Alzheimer's disease therapeutics — the hoechst experience
|
Siegfried, K.R
|
|
1991
|
1 |
3 |
p. 269-270
2 p.
|
artikel
|
| 29 |
A review of the efficacy and safety of paroxetine in elderly patients
|
Link, C.G.G
|
|
1991
|
1 |
3 |
p. 441-
1 p.
|
artikel
|
| 30 |
A single centre study comparing paroxetine and placebo in depressed outpatients
|
Smith, W.T
|
|
1991
|
1 |
3 |
p. 437-438
2 p.
|
artikel
|
| 31 |
A spin label study of ‘in vivo’ interactions of trifluoperazine with human cultured fibroblasts
|
Lejoyeux, M
|
|
1991
|
1 |
3 |
p. 411-
1 p.
|
artikel
|
| 32 |
Assessing memory function after single oral doses of buspirone and alprazolam in young healthy subjects
|
Bayés, M.C
|
|
1991
|
1 |
3 |
p. 421-422
2 p.
|
artikel
|
| 33 |
Assessment of the central effects of orthopramides in healthy subjects
|
Azcona, O
|
|
1991
|
1 |
3 |
p. 434-
1 p.
|
artikel
|
| 34 |
Behavioural and electrocorticographic studies in rodents with RP 59037, a cyclopyrrolone derivative partial agonist at the GABA receptor-complex
|
Stutzmann, J.M
|
|
1991
|
1 |
3 |
p. 397-
1 p.
|
artikel
|
| 35 |
Behavioural effects of ORG 2766 in autistic children
|
Buitelaar, J.K
|
|
1991
|
1 |
3 |
p. 391-393
3 p.
|
artikel
|
| 36 |
Benzodiazepine dependence in psychiatric emergencies
|
Alevizos, B
|
|
1991
|
1 |
3 |
p. 420-
1 p.
|
artikel
|
| 37 |
Benzodiazepine/GABAA receptors: the new findings from molecular biology and their implication for receptor nomenclature
|
Barnard, E.A
|
|
1991
|
1 |
3 |
p. 281-282
2 p.
|
artikel
|
| 38 |
B-HT 920 and EMD 49980 — novel dopamine autoreceptor agonists in the treatment of schizophrenia
|
Wiedemann, K
|
|
1991
|
1 |
3 |
p. 427-428
2 p.
|
artikel
|
| 39 |
Binding of 3H-spiperone to mononuclear cells of schizophrenics: relations to clinical variables and outcome
|
Bondy, B
|
|
1991
|
1 |
3 |
p. 459-460
2 p.
|
artikel
|
| 40 |
Biochemical and pharmacological properties of BW 1370U87 — a novel, selective monoamine oxidase A inhibitor
|
White, H.L
|
|
1991
|
1 |
3 |
p. 315-317
3 p.
|
artikel
|
| 41 |
Brain asymmetry in neural-immune interactions
|
Neveu, P.J
|
|
1991
|
1 |
3 |
p. 367-369
3 p.
|
artikel
|
| 42 |
Brofaromine: new biochemical findings with respect to reversibility
|
Waldmeier, P.C
|
|
1991
|
1 |
3 |
p. 324-326
3 p.
|
artikel
|
| 43 |
Bromocriptine, cyproheptadine and carbamazepine in combination to neuroleptics in chronic schizophrenia
|
Llorca, P.M
|
|
1991
|
1 |
3 |
p. 433-
1 p.
|
artikel
|
| 44 |
Buspirone effects in adolescent psychiatric disorders
|
Simeon, J.G
|
|
1991
|
1 |
3 |
p. 421-
1 p.
|
artikel
|
| 45 |
Caroxazone: a short-acting and reversible monoamine oxidase inhibitor with therapeutic potential for Parkinson's disease
|
Caccia, C
|
|
1991
|
1 |
3 |
p. 406-
1 p.
|
artikel
|
| 46 |
Changes in cerebral blood flow after diazepam evaluated with 3 measurement techniques
|
Mathew, R.J
|
|
1991
|
1 |
3 |
p. 471-
1 p.
|
artikel
|
| 47 |
Changes in GABAA receptor function by ‘in vivo’ administration of chemically different GABAergic drugs
|
Biggio, G
|
|
1991
|
1 |
3 |
p. 211-
1 p.
|
artikel
|
| 48 |
Cholecystokinin and panic disorders
|
Bourin, M
|
|
1991
|
1 |
3 |
p. 389-391
3 p.
|
artikel
|
| 49 |
Classification and determination of cerebral bioavailability of suriclone based on EEG brain mapping and psychometry
|
Saletu, B
|
|
1991
|
1 |
3 |
p. 474-
1 p.
|
artikel
|
| 50 |
Classification of tianeptine versus clomipramine and fluoxetine using EEG mapping kinetics
|
Luthringer, R
|
|
1991
|
1 |
3 |
p. 474-475
2 p.
|
artikel
|
| 51 |
Clinical and biological effects of clozapine in schizophrenic patients
|
Pickar, D
|
|
1991
|
1 |
3 |
p. 354-355
2 p.
|
artikel
|
| 52 |
Clinical, brain mapping and psychometric studies in negative schizophrenia: comparative trials with amisulpride and fluphenazine
|
Saletu, B
|
|
1991
|
1 |
3 |
p. 473-
1 p.
|
artikel
|
| 53 |
Comparative biochemical properties of paroxetine and other selective serotonin re-uptake inhibitors (SSRIs)
|
Nelson, D.R
|
|
1991
|
1 |
3 |
p. 401-402
2 p.
|
artikel
|
| 54 |
Comparative pharmacology of full and partial agonists at the benzodiazepine receptor
|
Schoch, P
|
|
1991
|
1 |
3 |
p. 201-202
2 p.
|
artikel
|
| 55 |
Comparison between paroxetine, imipramine and placebo in preventing recurrent major depressive episodes
|
Jakovljevic, M
|
|
1991
|
1 |
3 |
p. 440-
1 p.
|
artikel
|
| 56 |
Comparison of the panicogenic effects of cholecystokinin-tetrapeptide and 35% CO2 in normal subjects
|
Bradwejn, J
|
|
1991
|
1 |
3 |
p. 424-
1 p.
|
artikel
|
| 57 |
Comparison of three subgroups of antidepressant drugs according to their sleep EEG spectral profile
|
Minot, R
|
|
1991
|
1 |
3 |
p. 475-
1 p.
|
artikel
|
| 58 |
Conditions of injection during 99mTc HMPAO SPECT: possible influence in studies concerning Alzheimer's disease
|
Robert, Ph
|
|
1991
|
1 |
3 |
p. 468-
1 p.
|
artikel
|
| 59 |
Contingent Negative Variation and response to antidepressants
|
Papart, P
|
|
1991
|
1 |
3 |
p. 461-
1 p.
|
artikel
|
| 60 |
Correction of stress-induced changes by psychotropic drugs: role of histamine receptors and coupled adenylate cyclase
|
Meos, K
|
|
1991
|
1 |
3 |
p. 399-400
2 p.
|
artikel
|
| 61 |
Critical issues for the development of transplantation therapies in human neurodegenerative disorders
|
Lindvall, O
|
|
1991
|
1 |
3 |
p. 349-350
2 p.
|
artikel
|
| 62 |
Cross-national studies in Europe
|
|
|
1991
|
1 |
3 |
p. 366-
1 p.
|
artikel
|
| 63 |
Cytokines and sickness behaviour
|
Dantzer, R
|
|
1991
|
1 |
3 |
p. 377-379
3 p.
|
artikel
|
| 64 |
Dehydroepiandrosterone-sulphate (DHEAS) serum levels in normal aging and Alzheimer's disease (AD)
|
Windhager, E
|
|
1991
|
1 |
3 |
p. 426-
1 p.
|
artikel
|
| 65 |
Dementia and neuropeptides
|
Gottfries, C.G
|
|
1991
|
1 |
3 |
p. 393-396
4 p.
|
artikel
|
| 66 |
Depression and the immune system
|
Keller, S.E
|
|
1991
|
1 |
3 |
p. 369-371
3 p.
|
artikel
|
| 67 |
Development of an HPLC assay for plasma GABA and application in child psychiatry
|
DeVane, C.L
|
|
1991
|
1 |
3 |
p. 467-
1 p.
|
artikel
|
| 68 |
Dopamine receptor molecular genetics and circuits in CNS
|
Watson, S.J
|
|
1991
|
1 |
3 |
p. 351-
1 p.
|
artikel
|
| 69 |
Dopamine receptor occupancy measured in vivo during and following neuroleptic treatment
|
Baron, J.C
|
|
1991
|
1 |
3 |
p. 223-226
4 p.
|
artikel
|
| 70 |
Dopamine receptor subtypes: implications for development of new antipsychotic drugs
|
Seeman, P
|
|
1991
|
1 |
3 |
p. 249-
1 p.
|
artikel
|
| 71 |
Dopaminergic function in panic disorder
|
Pitchot, W
|
|
1991
|
1 |
3 |
p. 464-
1 p.
|
artikel
|
| 72 |
Dopaminergic mechanisms in an animal model of anhedonia
|
Willner, P
|
|
1991
|
1 |
3 |
p. 295-296
2 p.
|
artikel
|
| 73 |
Double-blind comparison of fluoxetine and clomipramine in obsessive-compulsive disorder
|
Saíz, J.
|
|
1991
|
1 |
3 |
p. 479-
1 p.
|
artikel
|
| 74 |
Double-blind comparison of remoxipride and haloperidol in acute treatment of schizophrenia: gender differences, clinical efficacy and extrapyramidal symptoms
|
Laux, G
|
|
1991
|
1 |
3 |
p. 432-433
2 p.
|
artikel
|
| 75 |
Drug long term treatment of affective disorders — outcome of a prospective longitudinal study
|
Neumann, N.-U
|
|
1991
|
1 |
3 |
p. 456-457
2 p.
|
artikel
|
| 76 |
Drug treatment of Alzheimer's disease — a clinician's view point
|
Wilcock, G.K
|
|
1991
|
1 |
3 |
p. 273-274
2 p.
|
artikel
|
| 77 |
Economic assessment of neuroleptic strategies in schizophrenia
|
Souêtre, E
|
|
1991
|
1 |
3 |
p. 435-
1 p.
|
artikel
|
| 78 |
Effect of caffeine and yohimbine in the induction of anxiety in healthy subjects: a preliminary report
|
Antonijoan, R.M
|
|
1991
|
1 |
3 |
p. 423-
1 p.
|
artikel
|
| 79 |
Effect of electroacupuncture on serotonergic activity in developing mammalian brain
|
Poddar, M.K
|
|
1991
|
1 |
3 |
p. 415-
1 p.
|
artikel
|
| 80 |
Effects of alimemazine, cyamemazine, propericiazine trihexyphenidyl and lithium on the sphingomyelinase activity of cultured human fibroblasts
|
Lejoyeux, M
|
|
1991
|
1 |
3 |
p. 412-
1 p.
|
artikel
|
| 81 |
Effects of non-competitive NMDA-receptor antagonists on the physiological function of A10 dopamine neurons
|
Svensson, T.H
|
|
1991
|
1 |
3 |
p. 413-
1 p.
|
artikel
|
| 82 |
Effects of the thiadiazolo-quinoline derivative RP 68303, a novel serotonin (5-HT) uptake inhibitor, on behaviour and sleep parameters in rodents
|
Piot, O
|
|
1991
|
1 |
3 |
p. 403-
1 p.
|
artikel
|
| 83 |
Effects of tianeptine and other antidepressants on the activity of medial septal neurons in rats anesthetized with urethane
|
Bassant, M.H
|
|
1991
|
1 |
3 |
p. 402-403
2 p.
|
artikel
|
| 84 |
Efficacy and safety of SND 919, a new dopamine autoreceptor agonist in schizophrenia
|
Kissling, W
|
|
1991
|
1 |
3 |
p. 427-
1 p.
|
artikel
|
| 85 |
Elevated caudate DOPA decarboxylase activity in vivo in schizophrenia and temporal lobe epilepsy with psychosis
|
Reith, J
|
|
1991
|
1 |
3 |
p. 472-
1 p.
|
artikel
|
| 86 |
Enzyme-activated reversible and highly selective MAO-B inhibition by Ro 19–6327: preclinical and clinical findings
|
Da Prada, M
|
|
1991
|
1 |
3 |
p. 321-323
3 p.
|
artikel
|
| 87 |
Epidemiology of psychotropic drug abuse
|
Schmidt, L.G
|
|
1991
|
1 |
3 |
p. 257-258
2 p.
|
artikel
|
| 88 |
Evolution of protirelin test results in major depression before and after drug treatment
|
Duval, F
|
|
1991
|
1 |
3 |
p. 336-337
2 p.
|
artikel
|
| 89 |
Fluoxetine or placebo in suicidal behaviour
|
Montgomery, S.A
|
|
1991
|
1 |
3 |
p. 448-
1 p.
|
artikel
|
| 90 |
Fluoxetine versus fluvoxamine in healthy volunteers
|
Dietzel, M
|
|
1991
|
1 |
3 |
p. 448-449
2 p.
|
artikel
|
| 91 |
Free radicals and cerebral ischemia
|
Fisher, M
|
|
1991
|
1 |
3 |
p. 246-247
2 p.
|
artikel
|
| 92 |
From laboratory to clinic, a clinical perspective on animal models of depression
|
Deakin, J.F.W
|
|
1991
|
1 |
3 |
p. 302-304
3 p.
|
artikel
|
| 93 |
Functional organization of the nicotinic acetylcholine receptor
|
Changeux, J.P
|
|
1991
|
1 |
3 |
p. 305-307
3 p.
|
artikel
|
| 94 |
Galanthamine as a useful therapeutic agent in Alzheimer's disease: results of a long-term treatment in a single case study
|
Hock, C
|
|
1991
|
1 |
3 |
p. 424-425
2 p.
|
artikel
|
| 95 |
Genetics of Alzheimer's disease
|
Hardy, J
|
|
1991
|
1 |
3 |
p. 348-349
2 p.
|
artikel
|
| 96 |
Glycine antagonists and partial agonists as novel anxiolytic/antidepressant agents
|
Trullas, R
|
|
1991
|
1 |
3 |
p. 205-207
3 p.
|
artikel
|
| 97 |
Heterogeneity of GABAA-receptors: impact on terminology
|
Mohler, H
|
|
1991
|
1 |
3 |
p. 286-
1 p.
|
artikel
|
| 98 |
High or low dependence and abuse potential of drugs in four hospitalized patients groups
|
Molnar, Gy
|
|
1991
|
1 |
3 |
p. 418-419
2 p.
|
artikel
|
| 99 |
5-HT2 agents in anxiety
|
Meert, T.F
|
|
1991
|
1 |
3 |
p. 209-211
3 p.
|
artikel
|
| 100 |
Human pharmaco-EEG of the reversible and selective MAO-A inhibitor brofaromine — comparison of different modes of data handling and statistical evaluation
|
Reimann, I.W
|
|
1991
|
1 |
3 |
p. 476-
1 p.
|
artikel
|
| 101 |
Imaging and quantification of peripheral type benzodiazepine binding (ω 3) sites in the central nervous system
|
MacKenzie, E.T
|
|
1991
|
1 |
3 |
p. 232-234
3 p.
|
artikel
|
| 102 |
Immunomodulatory treatment of Alzheimer's disease with peat extract. Preliminary study
|
Leszek, J
|
|
1991
|
1 |
3 |
p. 425-426
2 p.
|
artikel
|
| 103 |
Impact of affective illness on gene expression: rationale for long-term prophylaxis
|
Post, R.M
|
|
1991
|
1 |
3 |
p. 214-216
3 p.
|
artikel
|
| 104 |
Index of authors
|
|
|
1991
|
1 |
3 |
p. 481-485
5 p.
|
artikel
|
| 105 |
Interaction of angiotensin II with GABA-ergic and DA-ergic transmitter mechanisms in seizure susceptibility
|
Georgiev, V.P
|
|
1991
|
1 |
3 |
p. 416-
1 p.
|
artikel
|
| 106 |
Interaction of benzodiazepines and endogenous anxiogenic peptide ligands with the immune system: a new neuroimmunoregulatory loop
|
Zavala, F
|
|
1991
|
1 |
3 |
p. 372-374
3 p.
|
artikel
|
| 107 |
Interleukins in the brain
|
Berkenbosch, F
|
|
1991
|
1 |
3 |
p. 374-376
3 p.
|
artikel
|
| 108 |
Introduction
|
Spiegel, R
|
|
1991
|
1 |
3 |
p. 266-267
2 p.
|
artikel
|
| 109 |
In vivo functional imaging of human brain ischaemia
|
Frackowiak, R.S.J
|
|
1991
|
1 |
3 |
p. 242-243
2 p.
|
artikel
|
| 110 |
In vivo receptor occupancy by risperidone and ocaperidone in the rat brain, measured ex vivo by quantitative autoradiography
|
Schotte, A
|
|
1991
|
1 |
3 |
p. 417-418
2 p.
|
artikel
|
| 111 |
Ipsapirone in the treatment of bulimia nervosa — an open study
|
Geretsegger, C
|
|
1991
|
1 |
3 |
p. 436-437
2 p.
|
artikel
|
| 112 |
Is depression a mood disorder?
|
Van Praag, H.M
|
|
1991
|
1 |
3 |
p. 193-
1 p.
|
artikel
|
| 113 |
Long term studies with antidepressants: early experiences in paroxetine studies and effect on the design of newer studies
|
Wade, A
|
|
1991
|
1 |
3 |
p. 443-
1 p.
|
artikel
|
| 114 |
Long term treatment of anxiety disorders
|
Cassano, G
|
|
1991
|
1 |
3 |
p. 220-
1 p.
|
artikel
|
| 115 |
Long term treatment of depressive disorder: the effects of tianeptine in the prevention of relapse and recurrence
|
Raffaitin, F
|
|
1991
|
1 |
3 |
p. 452-
1 p.
|
artikel
|
| 116 |
Mechanism of action of clozapine — like atypical antipsychotic drugs
|
Meltzer, H.Y
|
|
1991
|
1 |
3 |
p. 351-
1 p.
|
artikel
|
| 117 |
Metabolism of biogenic amines at hyperbaric oxygen (6 ata) and specific protective properties of MAO-A inhibitors during oxygen convulsions
|
Goldina, O.A
|
|
1991
|
1 |
3 |
p. 408-
1 p.
|
artikel
|
| 118 |
Methodological problems in the evaluation of anti-ischemic agents in humans
|
Orgogozo, J.M
|
|
1991
|
1 |
3 |
p. 238-241
4 p.
|
artikel
|
| 119 |
Modulation of receptor-G protein complex function by psychotropic drugs and glucocorticoids: implications for anxiety disorder and depression
|
Lesch, K.-P
|
|
1991
|
1 |
3 |
p. 340-341
2 p.
|
artikel
|
| 120 |
Molecular genetics of catecholamines and manic depressive illness
|
Mallet, J
|
|
1991
|
1 |
3 |
p. 345-
1 p.
|
artikel
|
| 121 |
Molecular genetic studies in affective illness
|
Mendlewicz, J
|
|
1991
|
1 |
3 |
p. 194-196
3 p.
|
artikel
|
| 122 |
Molecular pharmacology of GABAA-receptors
|
Mohler, H
|
|
1991
|
1 |
3 |
p. 344-
1 p.
|
artikel
|
| 123 |
Molecular processes associated with Alzheimer's disease
|
Beyreuther, K
|
|
1991
|
1 |
3 |
p. 346-348
3 p.
|
artikel
|
| 124 |
Molecular structure and dynamics of dopamine, serotonin and the D2, 5-HT2 and 5-HT1A receptors
|
Dahl, S.G
|
|
1991
|
1 |
3 |
p. 310-311
2 p.
|
artikel
|
| 125 |
Molecular structure, motion and dynamics of alpha helical membrane active peptides
|
Rigler, R
|
|
1991
|
1 |
3 |
p. 309-
1 p.
|
artikel
|
| 126 |
99mTc — HMPAO — Single Photon Emission computerized tomography in the diagnosis of early dementia and depressive pseudodementia
|
Stoppe, G
|
|
1991
|
1 |
3 |
p. 469-
1 p.
|
artikel
|
| 127 |
Naloxone-precipitated release of noradrenaline, but not serotonin or dopamine, is increased in brain during withdrawal in morphine dependent rats: an in vivo microdialysis study
|
Silverstone, P.H
|
|
1991
|
1 |
3 |
p. 414-415
2 p.
|
artikel
|
| 128 |
Neuroendocrine and biochemical effects of moclobemide
|
Hatzimanolis, J
|
|
1991
|
1 |
3 |
p. 463-
1 p.
|
artikel
|
| 129 |
Neuroendocrine aspects of serotonin
|
Dinan, T.G
|
|
1991
|
1 |
3 |
p. 356-357
2 p.
|
artikel
|
| 130 |
Neuropeptides and sexual behaviour
|
Gessa, G.L
|
|
1991
|
1 |
3 |
p. 382-383
2 p.
|
artikel
|
| 131 |
Neuropharmacological and electrophysiological probes of the central serotonergic system in major depression
|
Kasper, S
|
|
1991
|
1 |
3 |
p. 460-
1 p.
|
artikel
|
| 132 |
Neuroprotective effects of glycosphingolipids in in-vitro and in-vivo models of neurotoxicity
|
Guidotti, A
|
|
1991
|
1 |
3 |
p. 248-
1 p.
|
artikel
|
| 133 |
New anticonvulsants with selective MAO-B inhibitory activity
|
Dostert, P
|
|
1991
|
1 |
3 |
p. 317-319
3 p.
|
artikel
|
| 134 |
No effect of remoxipride on the QT interval and QTc-results from a comparison of 3 dose ranges of remoxipride and haloperidol
|
Morrison, D
|
|
1991
|
1 |
3 |
p. 430-431
2 p.
|
artikel
|
| 135 |
Obsessive-compulsive disorder and other disorders
|
López-Ibor Jr., J.J
|
|
1991
|
1 |
3 |
p. 275-
1 p.
|
artikel
|
| 136 |
Occupancy of the central benzodiazepine receptors during benzodiazepine treatment determined by PET
|
Pauli, S
|
|
1991
|
1 |
3 |
p. 229-231
3 p.
|
artikel
|
| 137 |
On the central effects of increasing doses of buspirone: a pharmaco-EEG study utilizing imaging methods
|
Barbanoj, M.J
|
|
1991
|
1 |
3 |
p. 420-421
2 p.
|
artikel
|
| 138 |
Paroxetine and fluoxetine on food intake in rats and effect of paroxetine on body weight in depressed patients
|
Rasmussen, J.G.C
|
|
1991
|
1 |
3 |
p. 443-444
2 p.
|
artikel
|
| 139 |
Paroxetine in the treatment of melancholic and severely depressed hospitalised patients
|
Dunbar, G.C
|
|
1991
|
1 |
3 |
p. 439-440
2 p.
|
artikel
|
| 140 |
Paroxetine's effects on CSF concentrations of neurotransmitter metabolites in depressed patients
|
Lundmark, J
|
|
1991
|
1 |
3 |
p. 442-
1 p.
|
artikel
|
| 141 |
Paroxetine — the optimal dosing regimen for this new antidepressant
|
Dunner, D.L
|
|
1991
|
1 |
3 |
p. 437-
1 p.
|
artikel
|
| 142 |
Patterns of cocaine abuse and indications for treatment
|
Tempesta, E
|
|
1991
|
1 |
3 |
p. 259-261
3 p.
|
artikel
|
| 143 |
Peptides and sleep
|
Adrien, J
|
|
1991
|
1 |
3 |
p. 384-386
3 p.
|
artikel
|
| 144 |
PET studies of D1 and D2 dopamine receptors in drug naive schizophrenic patients
|
Sedval, G.C
|
|
1991
|
1 |
3 |
p. 221-223
3 p.
|
artikel
|
| 145 |
Phagocytic activity of monocytes of panic disorder patients during benzodiazepine receptor activation
|
Hirsch, S.R
|
|
1991
|
1 |
3 |
p. 465-
1 p.
|
artikel
|
| 146 |
Pharmacological and molecular basis for reclassifying peripheral-type benzodiazepine receptors as τ (tau) receptors
|
Parola, A.L
|
|
1991
|
1 |
3 |
p. 289-294
6 p.
|
artikel
|
| 147 |
Pharmacological aspects of gene transcription: the case of the dopamine D2 receptor
|
Rogue, P
|
|
1991
|
1 |
3 |
p. 409-
1 p.
|
artikel
|
| 148 |
Pharmacological models of depression and drug development
|
Porsolt, R.D
|
|
1991
|
1 |
3 |
p. 298-299
2 p.
|
artikel
|
| 149 |
Pilot study of flesinoxan, a 5-HT1A agonist, in major depression
|
Pitchot, W
|
|
1991
|
1 |
3 |
p. 436-
1 p.
|
artikel
|
| 150 |
P300 in posttraumatic stress disorder: preliminary results
|
Pitchot, W
|
|
1991
|
1 |
3 |
p. 465-466
2 p.
|
artikel
|
| 151 |
Placebo-controlled studies in acute schizophrenia — an issue of concern
|
Delini-Stula, A
|
|
1991
|
1 |
3 |
p. 478-479
2 p.
|
artikel
|
| 152 |
Plasma thyrotropin and duration of the ECT-induced seizures
|
Markianos, M
|
|
1991
|
1 |
3 |
p. 464-
1 p.
|
artikel
|
| 153 |
Positron emission tomographic studies of the central 5-HT system: presynaptic and postsynaptic
|
Hartvig, P
|
|
1991
|
1 |
3 |
p. 235-237
3 p.
|
artikel
|
| 154 |
Possible mechanisms underlying atypical neuroleptic drugs
|
Ögren, S.Ö
|
|
1991
|
1 |
3 |
p. 249-251
3 p.
|
artikel
|
| 155 |
Potent and selective irreversible inhibition of MAO-B by MDL 72,974A
|
Palfreyman, M.G
|
|
1991
|
1 |
3 |
p. 319-321
3 p.
|
artikel
|
| 156 |
Prolactin concentrations after single and repeated oral doses of savoxepine in patients with chronic schizophrenia
|
Cavallaro, R
|
|
1991
|
1 |
3 |
p. 434-435
2 p.
|
artikel
|
| 157 |
Proposal for an ‘omega modulatory site’ nomenclature to replace the benzodiazepine receptor denomination
|
Arbilla, S
|
|
1991
|
1 |
3 |
p. 282-285
4 p.
|
artikel
|
| 158 |
Proposal of a new GABAA-benzodiazepine receptor nomenclature based on the subunit composition of GABAA receptors
|
Sieghart, W
|
|
1991
|
1 |
3 |
p. 286-288
3 p.
|
artikel
|
| 159 |
Psychopathological, cognitive and neuroendocrine responses to treatment with amitriptyline in elderly depressed patients
|
Heuser, I.J
|
|
1991
|
1 |
3 |
p. 327-328
2 p.
|
artikel
|
| 160 |
Psychotogenic effect of pipemidinic acid
|
Kemperman, C.J.F
|
|
1991
|
1 |
3 |
p. 419-
1 p.
|
artikel
|
| 161 |
Rapid tolerance to the performance impairing properties of antidepressant drugs: a review of four psychometric studies
|
O'Hanlon, J.F
|
|
1991
|
1 |
3 |
p. 457-
1 p.
|
artikel
|
| 162 |
Regulation of dopamine D2 receptors: molecular mechanisms
|
Creese, Ian
|
|
1991
|
1 |
3 |
p. 408-409
2 p.
|
artikel
|
| 163 |
Remoxipride added to other neuroleptics in non-responding chronic schizophrenic patients
|
Holm, A-C
|
|
1991
|
1 |
3 |
p. 432-
1 p.
|
artikel
|
| 164 |
Remoxipride imipramine interaction
|
Yisak, W
|
|
1991
|
1 |
3 |
p. 431-432
2 p.
|
artikel
|
| 165 |
Remoxipride in long-term treatment of schizophrenia: results from an open long-term programme
|
Morrison, D
|
|
1991
|
1 |
3 |
p. 431-
1 p.
|
artikel
|
| 166 |
Research in antipsychotic treatment: perspectives and expectations
|
Fog, R
|
|
1991
|
1 |
3 |
p. 255-256
2 p.
|
artikel
|
| 167 |
Responses to cumulative doses of clonidine in healthy volunteers: cardiovascular, noradrenergic and subjective parameters
|
Tulen, J.H.M
|
|
1991
|
1 |
3 |
p. 466-
1 p.
|
artikel
|
| 168 |
Response to phenelzine and imipramine in placebo nonresponders with atypical depression
|
Quitkin, F.M
|
|
1991
|
1 |
3 |
p. 456-
1 p.
|
artikel
|
| 169 |
Response to therapeutic sleep deprivation and mapping of EEG and evoked potentials
|
Kasper, S
|
|
1991
|
1 |
3 |
p. 476-477
2 p.
|
artikel
|
| 170 |
Serotonergic probes in obsessive-compulsive disorder
|
Zohar, J
|
|
1991
|
1 |
3 |
p. 276-277
2 p.
|
artikel
|
| 171 |
Serotonin and dopamine metabolism in depressed patients and healthy volunteers — a PET study of [11C]L-DOPA uptake and utilization
|
Ågren, H
|
|
1991
|
1 |
3 |
p. 470-
1 p.
|
artikel
|
| 172 |
Serotonin and dopamine relationships in nonhuman primate extrapyramidal syndromes
|
Casey, D.E
|
|
1991
|
1 |
3 |
p. 351-353
3 p.
|
artikel
|
| 173 |
Serotonin and dopamine systems in obsessive compulsive disorders
|
Marazziti, D
|
|
1991
|
1 |
3 |
p. 462-463
2 p.
|
artikel
|
| 174 |
Serotonin and violent suicide attempts
|
Träskman-Bendz, L
|
|
1991
|
1 |
3 |
p. 361-363
3 p.
|
artikel
|
| 175 |
Serotoninergic approach: why serotoninergic substitution? Clinical experience with 5-HT uptake inhibitors
|
Gottfries, C.G
|
|
1991
|
1 |
3 |
p. 271-273
3 p.
|
artikel
|
| 176 |
Serotonin in alcoholism
|
Linnoila, M
|
|
1991
|
1 |
3 |
p. 360-361
2 p.
|
artikel
|
| 177 |
Serotonin in panic, anxiety and depression
|
Deakin, J.F.W
|
|
1991
|
1 |
3 |
p. 358-360
3 p.
|
artikel
|
| 178 |
Sertraline and dothiepin in the treatment of depression in general practice — a placebo controlled study
|
Langdon, C.G
|
|
1991
|
1 |
3 |
p. 445-446
2 p.
|
artikel
|
| 179 |
Sertraline in the treatment of major depression: an open clinical stratification study in Italian outpatients
|
Bersani, G
|
|
1991
|
1 |
3 |
p. 444-445
2 p.
|
artikel
|
| 180 |
Serum melatonin, 5-HT and tryptophan levels in blood and CSF in the diagnosis of early dementia and depressive pseudodementia
|
Müller-Spahn, F
|
|
1991
|
1 |
3 |
p. 458-
1 p.
|
artikel
|
| 181 |
Sigma receptor characterized with (+)-[3H]-3-(3-hydroxyphenyl)-N-(1-propyl)-piperidine on C6 glioma cells is a putative K+ channel
|
Jeanjean, A.P
|
|
1991
|
1 |
3 |
p. 412-413
2 p.
|
artikel
|
| 182 |
Significance of cerebrospinal fluid analyses in the diagnosis of dementia disorders
|
Blennow, K
|
|
1991
|
1 |
3 |
p. 457-458
2 p.
|
artikel
|
| 183 |
Significance of computerized tomography in the diagnosis of Alzheimer's disease and other dementia disorders
|
Wallin, A
|
|
1991
|
1 |
3 |
p. 469-
1 p.
|
artikel
|
| 184 |
Sleep and hormones
|
Holsboer, F
|
|
1991
|
1 |
3 |
p. 199-200
2 p.
|
artikel
|
| 185 |
Social stress of crowding reduces the pituitary-adrenocortical responsiveness to monoaminergic stimulation
|
Bugajski, J
|
|
1991
|
1 |
3 |
p. 399-
1 p.
|
artikel
|
| 186 |
Specific uptake of dopamine into mononuclear cells of psychiatric patients and healthy controls
|
Bondy, B
|
|
1991
|
1 |
3 |
p. 458-459
2 p.
|
artikel
|
| 187 |
SPECT-imaging of 5-HT2 receptors in depression
|
D'Haenen, H
|
|
1991
|
1 |
3 |
p. 471-
1 p.
|
artikel
|
| 188 |
Stimulation and inhibition of the pituitary-adrenal axis in depressed patients and control subjects
|
Gispen-De Wied, C.C
|
|
1991
|
1 |
3 |
p. 328-335
8 p.
|
artikel
|
| 189 |
Strategies for establishing long term efficacy of antidepressants
|
Montgomery, S.A
|
|
1991
|
1 |
3 |
p. 218-220
3 p.
|
artikel
|
| 190 |
Structure and pharmacology of voltage-sensitive K+ channels
|
Barhanin, B
|
|
1991
|
1 |
3 |
p. 307-309
3 p.
|
artikel
|
| 191 |
Suicidal behavior and growth hormone response to apomorphine test
|
Pitchot, W
|
|
1991
|
1 |
3 |
p. 462-
1 p.
|
artikel
|
| 192 |
Switch from a nonselective irreversible MAOI to moclobemide: Efficacy and tolerability
|
Bougerol, T
|
|
1991
|
1 |
3 |
p. 453-
1 p.
|
artikel
|
| 193 |
The ACTH-(4–9) analog ORG 2766 and postlesion plasticity in the brain
|
Van Ree, J.M
|
|
1991
|
1 |
3 |
p. 386-388
3 p.
|
artikel
|
| 194 |
The central benzodiazepine receptor (cBZR): studies by PET
|
Abadie, P
|
|
1991
|
1 |
3 |
p. 226-229
4 p.
|
artikel
|
| 195 |
The clomipramine challenge test in obsessive compulsive disorder
|
Saíz, J
|
|
1991
|
1 |
3 |
p. 280-
1 p.
|
artikel
|
| 196 |
The dexamethasone-hCRH stimulation test and cognitive performance during antidepressive treatment with trimipramine
|
Holsboer-Trachsler, E
|
|
1991
|
1 |
3 |
p. 338-340
3 p.
|
artikel
|
| 197 |
The differential clinical therapeutic profiles of O-substituted benzamides considered with regard to their mechanisms of action
|
Ackenheil, M
|
|
1991
|
1 |
3 |
p. 252-253
2 p.
|
artikel
|
| 198 |
The dopamine D3 receptor as a novel target for antipsychotics
|
Schwartz, J.C
|
|
1991
|
1 |
3 |
p. 197-199
3 p.
|
artikel
|
| 199 |
The effect of neuroleptic drugs on individual different responses of rats to apomorphine
|
Havemann-Reinecke, U
|
|
1991
|
1 |
3 |
p. 410-
1 p.
|
artikel
|
| 200 |
The effect of 10-week administration of sabeluzole on the brain function in old rats
|
Benesova, O
|
|
1991
|
1 |
3 |
p. 405-406
2 p.
|
artikel
|
| 201 |
The effects of nicardipine and nitrendipine on hypoxia induced memory impairment in the rat
|
Zupan, G
|
|
1991
|
1 |
3 |
p. 407-
1 p.
|
artikel
|
| 202 |
The efficacy and safety of sertraline versus imipramine in outpatients with major depression: a six month double-blind, parallel multicenter study
|
Fontaine, R
|
|
1991
|
1 |
3 |
p. 447-
1 p.
|
artikel
|
| 203 |
The efficacy of a reversible MAO-A-inhibitor brofaromine, in panic disorder and social phobia: behavioural and biochemical results
|
Van Vliet, I.M
|
|
1991
|
1 |
3 |
p. 454-
1 p.
|
artikel
|
| 204 |
The epidemiology of recurrent depression
|
Angst, J
|
|
1991
|
1 |
3 |
p. 212-213
2 p.
|
artikel
|
| 205 |
The french THA multicenter trial: purpose, design and discussion of the methodology used
|
Forette, F
|
|
1991
|
1 |
3 |
p. 267-269
3 p.
|
artikel
|
| 206 |
The imidazopyridine derivatives zolpidem and alpidem discriminate between central ω (benzodiazepine) receptor subtypes in rat brain sections
|
Benavides, J
|
|
1991
|
1 |
3 |
p. 398-
1 p.
|
artikel
|
| 207 |
The influence of calcium channel blockers nimodipine, nifedipine and amlodipine on passive avoidance in hypoxia exposed rats
|
Simonic, A
|
|
1991
|
1 |
3 |
p. 407-408
2 p.
|
artikel
|
| 208 |
The influence of desipramine and fluoxetine on MK-801-induced locomotor hyperactivity and dopamine release
|
Wedzony, K
|
|
1991
|
1 |
3 |
p. 401-
1 p.
|
artikel
|
| 209 |
The lack of potential for paroxetine to produce evidence of lipidosis in human blood leucocytes
|
White, D.J
|
|
1991
|
1 |
3 |
p. 444-
1 p.
|
artikel
|
| 210 |
The mitochondrial benzodiazepine receptor (MBR): biochemistry and function
|
Costa, E
|
|
1991
|
1 |
3 |
p. 288-289
2 p.
|
artikel
|
| 211 |
The potential of NMDA antagonists for stroke treatment
|
Scatton, B
|
|
1991
|
1 |
3 |
p. 244-246
3 p.
|
artikel
|
| 212 |
The preference of psychotropic drugs abused by patients in a methadone maintenance program
|
Barnas, C
|
|
1991
|
1 |
3 |
p. 263-265
3 p.
|
artikel
|
| 213 |
Therapeutic profile of atypical antipsychotic drugs
|
Charney, D.S
|
|
1991
|
1 |
3 |
p. 353-
1 p.
|
artikel
|
| 214 |
The role of cytokines in neural pathology
|
Benavides, J
|
|
1991
|
1 |
3 |
p. 379-381
3 p.
|
artikel
|
| 215 |
The role of serotonin in behavioural abnormalities
|
Marazziti, D
|
|
1991
|
1 |
3 |
p. 461-462
2 p.
|
artikel
|
| 216 |
The role of serotonin re-uptake inhibitors in forensic psychiatry
|
Bradford, J.M.W
|
|
1991
|
1 |
3 |
p. 364-365
2 p.
|
artikel
|
| 217 |
The safety of a rapid switch from tricyclic antidepressants to brofaromine
|
Cornaggia, C
|
|
1991
|
1 |
3 |
p. 452-453
2 p.
|
artikel
|
| 218 |
The selectivity of anterograde amnesia caused by single doses of ethanol, lorazepam, and scopolamine in young volunteers
|
Satzger, W
|
|
1991
|
1 |
3 |
p. 422-423
2 p.
|
artikel
|
| 219 |
The serotonin reuptake inhibitor clomipramine markedly reduces premenstrual irritability and dysphoria in women suffering from premenstrual syndrome
|
Sundblad, C
|
|
1991
|
1 |
3 |
p. 450-451
2 p.
|
artikel
|
| 220 |
The therapeutic outcome in schizophrenia of new DA receptor antagonists and agonists in comparison with classical neuroleptic drugs
|
Lewander, T
|
|
1991
|
1 |
3 |
p. 253-255
3 p.
|
artikel
|
| 221 |
Three-dimensional structure of bacteriorhodopsin
|
Ceska, T.A
|
|
1991
|
1 |
3 |
p. 311-312
2 p.
|
artikel
|
| 222 |
Tolerability and safety of combined fluoxamine and moclobemide in healthy volunteers
|
Dingemanse, J
|
|
1991
|
1 |
3 |
p. 455-
1 p.
|
artikel
|
| 223 |
Tolerance and dependence on the benzodiazepines
|
Lader, M.H
|
|
1991
|
1 |
3 |
p. 261-263
3 p.
|
artikel
|
| 224 |
Treatment of ischemic stroke in humans: general problems
|
Bogousslavsky, J
|
|
1991
|
1 |
3 |
p. 241-242
2 p.
|
artikel
|
| 225 |
Treatment response in obsessive compulsive disorder
|
Fineberg, N.A
|
|
1991
|
1 |
3 |
p. 277-279
3 p.
|
artikel
|
| 226 |
Upregulation of [3H]MK-801 binding in the rat cerebellar cortex induced by degeneration of climbing fibers
|
Serra, M
|
|
1991
|
1 |
3 |
p. 414-
1 p.
|
artikel
|
| 227 |
Zalospirone, Wy-50,324, and WAY-100,289: new serotonergic agents with psychotherapeutic potential
|
Muth, E.A
|
|
1991
|
1 |
3 |
p. 207-209
3 p.
|
artikel
|
| 228 |
Zotepine: its clinical efficacy considered in relation to its effect on neurotransmitter-receptor systems
|
Ackenheil, M
|
|
1991
|
1 |
3 |
p. 429-430
2 p.
|
artikel
|
Tijdschrift beschrijving